Medavante Inc Information

Leading global provider of centralized expert psychiatric and neurocognition rating and monitoring services for CNS clinical trials in the pharmaceutical, biotechnology and medical device industries through unique signal detection methodologies developed by thought leaders in psychiatric assessment, cognitive testing, drug development and academia to systematically remove potential sources of bias and variability from screening and outcome assessments to enable standardization of assessments and rater blinding to eliminate bias, reduce error variability, increase accuracy of outcomes.